Bicalutamide With or Without Enzastaurin in Treating Patients With Prostate Cancer

NCT00685633 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

NETWORK

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: bicalutamide
DRUG: enzastaurin hydrochloride

Sponsor

Eastern Cooperative Oncology Group

Collaborators

[object Object]